Stanley Lewis

Dr. Stanley Lewis joined Ansun in 2018 as its Chief Medical Officer. Prior to that, he was the Vice President, Chief Medical Officer of Taimed Biologics where he led the clinical development of Trogarzo® from Phase 1 to BLA licensure in March of 2018. Prior to that he was the Director of Drug Development at Tanox and later a Medical Director at Genentech after which he joined Taimed to lead the Trogarzo® team. He received his M.D. from the University of Texas Medical School and served as a Assistant Professor of Medicine there from 1996-2004. Dr. Lewis is a seasoned CMO with a proven track record.